Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Immune Deficiency in Adults”

60 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 60 results

Testing effectiveness (Phase 2)Looking for participantsNCT03266653
What this trial is testing

EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection

Who this might be right for
Epstein-Barr Virus InfectionsPrimary Immune Deficiency Disorder
New York Medical College 20
Testing effectiveness (Phase 2)Looking for participantsNCT03266640
What this trial is testing

Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV)

Who this might be right for
Cytomegalovirus InfectionsPrimary Immune Deficiency Disorder
New York Medical College 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT05120830
What this trial is testing

NTLA-2002 in Adults With Hereditary Angioedema (HAE)

Who this might be right for
Hereditary Angioedema
Intellia Therapeutics 37
Large-scale testing (Phase 3)Study completedNCT01581593
What this trial is testing

Efficacy and Safety Study of Kedrion IVIG 10% to Treat Subjects With Primary Immunodeficiency (PID)

Who this might be right for
Primary ImmunodeficiencyAgammaglobulinemiaHypogammaglobulinemia+1 more
Kedrion S.p.A. 45
Not applicableActive Not RecruitingNCT05236764
What this trial is testing

Haploidentical Hematopoietic Cell Transplantation Using TCR Alpha/Beta and CD19 Depletion

Who this might be right for
Acute Lymphoblastic Leukemia in RemissionAcute Myeloid Leukemia in RemissionMyelodysplastic Syndromes+8 more
Baylor College of Medicine 3
Large-scale testing (Phase 3)Looking for participantsNCT06679881
What this trial is testing

Long-Term, Open-label Study of Oral Deucrictibant Extended-Release Tablet for Prophylaxis Against Angioedema Attacks in Adolescents and Adults With HAE

Who this might be right for
Hereditary Angioedema (HAE)
Pharvaris Netherlands B.V. 170
Not applicableLooking for participantsNCT07263685
What this trial is testing

Lanadelumab in Teenagers and Adults With Hereditary Angioedema (HAE) in the Kingdom of Saudi Arabia

Who this might be right for
Hereditary Angioedema (HAE)
Takeda 50
Not applicableNo Longer AvailableNCT04583007
What this trial is testing

Expanded Access for the Prevention of Acute Attacks of 1) Hereditary Angioedema (HAE) in Children and 2) Non-histaminergic Angioedema With Normal C1-Inhibitor (C1-INH) in Teenagers and Adults

Who this might be right for
Hereditary Angioedema (HAE)Angioedema
Shire
Not applicableStudy completedNCT05489640
What this trial is testing

A Study in Adults With Hereditary Angioedema (HAE) Who Currently Receive Icatibant at Home

Who this might be right for
Hereditary Angioedema (HAE)
Takeda 85
Testing effectiveness (Phase 2)Study completedNCT01095497
What this trial is testing

Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Subcutaneous CINRYZE Administration

Who this might be right for
Hereditary Angioedema
Shire 26
Large-scale testing (Phase 3)Active Not RecruitingNCT06669754
What this trial is testing

Study of Oral Deucrictibant Extended-Release Tablet for Prophylaxis Against Angioedema Attacks in Adolescents and Adults With HAE

Who this might be right for
Hereditary Angioedema (HAE)
Pharvaris Netherlands B.V. 81
Not applicableWithdrawnNCT04331483
What this trial is testing

Assess a Physical Activity Program in Children, Adolescents and Young Adults Requiring Hematopoietic Stem Cell Allografts

Who this might be right for
Haematological MalignancyAcute LeukemiaMyelodysplastic Syndromes+3 more
Centre Leon Berard
Not applicableStudy completedNCT04963660
What this trial is testing

Primary Immunodeficiencies in Costa Rican Adults

Who this might be right for
Primary Immune Deficiency in Adults
Caja Costarricense de Seguro Social 137
Early research (Phase 1)Study completedNCT05477160
What this trial is testing

STAR-0215 in Healthy Adult Participants

Who this might be right for
Hereditary Angioedema
Astria Therapeutics, Inc. 41
Not applicableActive Not RecruitingNCT05469789
What this trial is testing

Lanadelumab in Teenagers and Adults With Hereditary Angioedema (HAE)

Who this might be right for
Hereditary Angioedema (HAE)
Takeda 50
Large-scale testing (Phase 3)Study completedNCT06343779
What this trial is testing

Study of Oral Deucrictibant Soft Capsule for On-Demand Treatment of Angioedema Attacks in Adolescents and Adults With Hereditary Angioedema

Who this might be right for
Hereditary AngioedemaHereditary Angioedema Type IHereditary Angioedema Type II+11 more
Pharvaris Netherlands B.V. 134
Not applicableStudy completedNCT04861090
What this trial is testing

A Study in Teenagers and Adults With Hereditary Angioedema (HAE) Type I or Type II Who Use Lanadelumab as Long-Term Prophylaxis

Who this might be right for
Hereditary Angioedema (HAE)
Takeda 207
Testing effectiveness (Phase 2)Study completedNCT00053989
What this trial is testing

NMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/Disorders

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+5 more
Roswell Park Cancer Institute 41
Testing effectiveness (Phase 2)Study completedNCT01529827
What this trial is testing

Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+75 more
Roswell Park Cancer Institute 94
Testing effectiveness (Phase 2)Looking for participantsNCT01962415
What this trial is testing

Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT

Who this might be right for
Primary Immunodeficiency (PID)Congenital Bone Marrow Failure SyndromesInherited Metabolic Disorders (IMD)+4 more
Paul Szabolcs 100
Load More Results